Screening: BRCA testing in women younger than 50 with triple-negative breast cancer is cost effective

Nature Reviews Clinical Oncology

Volumn 7, Issue 11, 2010, Pages 611-

  Hutchinson, Lisa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRCA PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; FAMILY HISTORY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; JEW; OVARY CANCER; PRIORITY JOURNAL; SCREENING; TRIPLE NEGATIVE BREAST CANCER; UNITED STATES;

EID: 78049461605     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2010.164     Document Type: Article

References (1)

1. ORIGINAL ARTICLE Kwon, J. S. et al. Expanding the criteria for BRCA mutation testing in breast cancer survivors. J. Clin. Oncol. 28, 4214-4220 (2010)